/AMGEN%20Inc_%20logo%20on%20meds-by%20Melnikov%20Dmitriy%20via%20Shutterstock.jpg)
Amgen (AMGN) is a biotech company based in California. It specializes in developing treatments for cardiovascular conditions, oncology, hematology, neurology, bone health, nephrology, and more.
Amgen’s stock has grown steadily this year, gaining 20% in 2025. However, shares are still trading roughly 10% below their 52-week high of $346.85.